Could a common blood thinner help fight ovarian cancer?
NCT ID NCT05284552
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether adding the blood thinner tinzaparin to standard chemotherapy can improve outcomes for women with advanced ovarian cancer. About 40 participants will receive either chemotherapy plus tinzaparin or chemotherapy alone. The main goal is to see if tinzaparin affects a key tumor marker called CA-125.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tinzaparin (Innohep), a blood thinner
What this could lead to
If it works, this could point toward a way to make chemotherapy more effective for advanced ovarian cancer.
What could go wrong
This is a very small, early pilot study. It may not show a clear benefit, and the blood thinner carries a risk of bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Obstetrics and Gynaecology, Norrland University Hospital
RECRUITINGUmeå, Umeå, 90719, Sweden
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Obstetrics and Gynecology, Highland Hospital
RECRUITINGEksjö, Eksjö, 575 81, Sweden
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Department of Obstetrics and Gynecology, Ryhov County Hospital
RECRUITINGJönköping, Jönköping County, 55305, Sweden
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Department of Obstetrics and Gynecology, University Hospital
ACTIVE_NOT_RECRUITINGLinköping, Östergötland County, 58185, Sweden
-
Department of Obstetrics and Gynecology, Värnamo Hospital
RECRUITINGVärnamo, Värnamo, 33152, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Obstetrics and Gynecology, Västervik Hospital
RECRUITINGVästervik, Västervik, 593 81, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Department of Oncology, Linköping University Hospital
RECRUITINGLinköping, Linköping, 58185, Sweden
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
Department of Oncology, Sahlgrenska University Hospital
RECRUITINGGothenburg, Gothenburg, 41345, Sweden
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact